European Oncology Market Access Leader

Summit Therapeutics; Zug; On-site; CHF 180,000 - 260,000; Full time

Job summary

Summit Therapeutics is seeking a highly strategic European Market Access Leader to drive pricing, reimbursement, HTA submissions, and patient access for our oncology portfolio across Europe. The role focuses on NSCLC, CRC, and bladder cancer with strong payer engagement across EU5 and additional markets.

The successful candidate will lead cross-functional teams, influence portfolio strategy, and ensure timely access with sustainable pricing while building enduring relationships with European

Qualifications

• Advanced degree in life sciences, pharmacy, medicine, health economics, public health, business, or related discipline.
• MBA/PhD/MD preferred.

Responsibilities

• Lead development of European market access strategy across major markets (EU5 plus key European countries).
• Drive pricing, reimbursement, HTA submissions, and value proposition for NSCLC, CRC, and bladder cancer.
• Partner with Global teams to align evidence generation with payer requirements and launch readiness.
• Engage payers, HTA bodies, and stakeholders to optimize patient access and lifecycle management.

Skills

Market access strategy

HTA expertise

Oncology knowledge

Stakeholder management

Executive communications

Education

Advanced degree in life sciences or related

Job description

Summit Therapeutics is seeking a highly strategic European Market Access Leader to drive pricing, reimbursement, HTA submissions, and patient access for our oncology portfolio across Europe. The role focuses on NSCLC, CRC, and bladder cancer with strong payer engagement across EU5 and additional markets.

The successful candidate will lead cross-functional teams, influence portfolio strategy, and ensure timely access with sustainable pricing while building enduring relationships with European